Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

Coralie  Briand; Marie-Louise  Frémond; Didier Bessis; Aurelia Carbasse; Gillian I. Rice; Vincent  Bondet; Darragh  Duffy; Stéphane Blanche; Yanick Crow; Bénédicte  Neven

doi:10.1136/annrheumdis-2018-214037

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

Coralie Briand, Marie-Louise Frémond, Didier Bessis, Aurelia Carbasse, Gillian I. Rice, Vincent Bondet, Darragh Duffy, Stéphane Blanche, Yanick Crow, Bénédicte Neven

Research output: Contribution to journal › Letter › peer-review

Original language	English
Journal	Annals of the Rheumatic Diseases
Early online date	3 Oct 2018
DOIs	https://doi.org/10.1136/annrheumdis-2018-214037
Publication status	E-pub ahead of print - 3 Oct 2018

Access to Document

10.1136/annrheumdis-2018-214037

Briand et al_V3_YJC_AcceptedAccepted author manuscript, 41.5 KBLicence: Creative Commons: Attribution Non-Commercial (CC-BY-NC)

Definition and characterization of type I interferonopathies
Crow, Y.
EU government bodies
1/03/18 → 31/10/18
Project: Research

Cite this

@article{e7976a18834e469f944890a782d25ec3,

title = "Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency",

author = "Coralie Briand and Marie-Louise Fr{\'e}mond and Didier Bessis and Aurelia Carbasse and Rice, {Gillian I.} and Vincent Bondet and Darragh Duffy and St{\'e}phane Blanche and Yanick Crow and B{\'e}n{\'e}dicte Neven",

year = "2018",

month = oct,

day = "3",

doi = "10.1136/annrheumdis-2018-214037",

language = "English",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

AU - Briand, Coralie

AU - Frémond, Marie-Louise

AU - Bessis, Didier

AU - Carbasse, Aurelia

AU - Rice, Gillian I.

AU - Bondet, Vincent

AU - Duffy, Darragh

AU - Blanche, Stéphane

AU - Crow, Yanick

AU - Neven, Bénédicte

PY - 2018/10/3

Y1 - 2018/10/3

U2 - 10.1136/annrheumdis-2018-214037

DO - 10.1136/annrheumdis-2018-214037

M3 - Letter

SN - 0003-4967

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

ER -

Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency

Access to Document

Projects

Definition and characterization of type I interferonopathies

Cite this